The impact of high eosinophil count on hospitalizations in COPD patients Source: International Congress 2018 – Biomarkers of COPD Year: 2018
Variability in eosinophil levels at start of severe exacerbations of COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020
Minimal effect of inhaled corticosteroids (ICS) on blood eosinophil count in steroid-naïve COPD patients Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015
COPD severity and health impact across the current CanCOLD population Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012
Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019
Role of sputum eosinophil levels in the assessment of asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004
The assesment of serum TNFα levels in COPD acute exacerbation and the effects of inhaler steroids on clinical and inflammatory determinants Source: Eur Respir J 2002; 20: Suppl. 38, 312s Year: 2002
LATE-BREAKING ABSTRACT: Tiotropium efficacy and exacerbation risk in patients with different blood eosinophil levels Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015
Evaluation of the association between eosinophil variability and effects of inhaled corticosteroids in COPD patients using propensity score matching Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019
The impact of asthma and/or COPD on work absence Source: International Congress 2018 – Primary care management of asthma Year: 2018
Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study Source: ERJ Open Res, 4 (3) 00022-2018; 10.1183/23120541.00022-2018 Year: 2018
CD8+ve airway inflammation in COPD: The impact of smoking status Source: Annual Congress 2003 - Cigarette smoke: how it does its dirty work Year: 2003
The impact of COVID-19 on patients with asthma Source: Eur Respir J, 57 (3) 2003142; 10.1183/13993003.03142-2020 Year: 2021
The impact of spirometery on family physician‘s care of asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 670s Year: 2005
Does eosinophil cationic protein (ECP) predict asthma outcome and response to treatment in asthmatic patients? Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Correlations between exacerbation rate and blood eosinophil levels in COPD patients Source: International Congress 2017 – Infection and exacerbation science Year: 2017
Can plasma arginase levels differantiate asthma and COPD? Source: Eur Respir J 2007; 30: Suppl. 51, 372s Year: 2007
Sputum eosinophil counts in a large population of mild-to-moderate asthmatics: distribution, relationship with methacholine bronchial responsiveness and influence of a regular treatment with low doses of inhaled corticosteroids Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001
Association between blood eosinophil count and risk of exacerbations in patients with COPD Source: International Congress 2017 – Biomarker-based asthma control Year: 2017
Impact of the eosinophil variability on severe exacerbations in an asthmatic population Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes Year: 2020